CNMD Conmed Corp
Updated
Healthcare · Electromedical & Electrotherapeutic Apparatus
Conmed Corp (CNMD) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $1.5 billion. Shares last traded at $49.48, 12.3% below their 52-week high. Over the past year the stock is down 6.2%. CNMD trades at a price-to-earnings ratio of 31.46, above the Electromedical & Electrotherapeutic Apparatus median of 23.73. Net profit margin is 3.4%, above the peer median of -8.4%. Revenue grew 5.2% year over year. The shares yield 1.6% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
CNMD Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $25M | $0.79 | 53% |
| 2024-12-31 | $25M | $0.79 | 19% |
| 2023-12-31 | $25M | $0.78 | 38% |
| 2022-12-31 | $24M | $0.80 | — |
| 2021-12-31 | $23M | $0.72 | 37% |
| 2020-12-31 | $23M | $0.77 | 240% |
| 2019-12-31 | $23M | $0.77 | 79% |
| 2018-12-31 | $22M | $0.78 | 55% |
| 2017-12-31 | $22M | $0.79 | 40% |
| 2016-12-31 | $22M | $0.79 | 151% |
| 2015-12-31 | $22M | $0.79 | 72% |
| 2014-12-31 | $22M | $0.79 | 68% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $1.22 | 2026-07-29 |
| FY 2025 | $1.51 | 2026-02-17 |
| Q3 2025 | $0.97 | 2025-11-06 |
| Q2 2026 | $0.88 | 2026-07-29 |
| Q1 2025 | $0.19 | 2025-05-01 |
| FY 2025 | $4.25 | 2026-02-17 |
Electromedical & Electrotherapeutic Apparatus peers
CNMD vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap. Updated
| MDT | Medtronic | $119.1B | 22.77 | 3.17 | 13.9% | +0.91% |
| LIVN | Livanova Plc | $4.5B | 23.73 | 3.04 | 12.8% | -1.46% |
| ITGR | Integer Holdings Corp | $4.3B | 33.23 | 2.31 | 7.0% | +0.16% |
| TMDX | Transmedics Group, Inc. | $3.0B | 19.87 | 4.51 | 22.7% | +3.06% |
| AXGN | Axogen, Inc. | $2.5B | -75.46 | 10.08 | -13.4% | -2.57% |
| BLFS | Biolife Solutions Inc | $1.7B | 29.96 | 16.90 | 56.4% | -1.15% |
| CNMD | Conmed Corp | $1.5B | 31.46 | 1.08 | 3.4% | +0.05% |
| CBLL | Ceribell, Inc. | $946M | -14.34 | 9.28 | -64.7% | -0.60% |
| CV | CapsoVision, Inc | $299M | -10.03 | — | — | +0.67% |
| ELMD | Electromed, Inc. | $229M | 20.31 | 3.11 | 15.3% | -2.95% |
| STXS | Stereotaxis, Inc. | $139M | -6.24 | 4.63 | -74.2% | +0.00% |
| VANI | Vivani Medical, Inc. | $124M | -4.73 | 262.06 | — | -4.17% |
| NXL | Nexalin Technology, Inc. | $117M | -12.99 | 537.83 | — | -22.06% |
| ECOR | electroCore, Inc. | $84M | -5.67 | 2.27 | -40.0% | -2.21% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.